Each one in plain English, with the numbers worked through for a shareholder.
1 Apr 2026capital raising announcement▲ GoodMajor
Dateline raised A$50m in a placement at A$0.40 per share (125m shares, about 3.3%), lifting cash to about A$96m. Funds go to enabling works, equipment, and equity for future project finance. BFS now due April 2026, slipping from end March; Ernst & Young appointed international auditor for SEC registration.
What it means for a shareholder
125m new shares at about A$0.400 to raise about A$50.0m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
23 Jan 2026capital raising announcement▲ GoodMajor
Dateline raised A$35m in an institutional placement at A$0.31 per share (112.9m shares, 3.1% of capital), lifting cash to over A$58m. Directors committed A$1.35m, subject to shareholder approval. Funds go to the Colosseum BFS, drilling and long-lead items; it also plans a shift to US reporting standards. This explains the 21 January trading pause.
What it means for a shareholder
113m new shares at about A$0.310 to raise about A$35.0m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
Dateline raised A$25m from institutions at A$0.215 per share (116.3m new shares, ~3.5% of enlarged capital), lifting cash to over A$35m. Shaw and Partners led for a 6% fee. Funds go to Colosseum; the company also begins SEC registration steps.
What it means for a shareholder
116m new shares at about A$0.215 to raise about A$25.0m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
25 June 2025capital raising announcement▲ GoodMajor
Managing Director Stephen Baghdadi exercised 53,000,208 options, putting over A$1.06m of cash into Dateline and lifting his holding to 396,890,307 shares (12.85%). He says cash at bank plus option exercise commitments is almost A$9m, following earlier option exercises.
19 May 2025capital raising announcement▲ GoodMajor
Cash at bank is about A$1.95m, including about A$1.1m from option exercises, rising to about A$2.3m after the Udu cash payment. Dateline says this fully funds the Colosseum feasibility study, easing the low-cash concern from December.
A second placement of 100 million shares at A$0.007 to an institutional investor raised A$700,000, with 50 million options at A$0.02. Total from the two placements is A$1.4m; no further placements are currently planned.
What it means for a shareholder
100m new shares at A$0.007 to raise about A$700,000. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
Dateline placed 100 million shares at A$0.007 to a US strategic investor, raising A$700,000, with 50 million options at A$0.02 expiring 2 August 2026. No fees paid; funds go to the Colosseum feasibility study.
What it means for a shareholder
100m new shares at A$0.007 to raise about A$700,000. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
Supplementary prospectus records the shortfall and follow-on placements, giving 2.49bn shares on issue after issuing 1.04bn new shares. Planned use of the $6.22m includes $1.35m of debt reduction and $1.4m for a mine planning study. Non-participants are diluted 41.51%.
27 Aug 2024capital raising announcement▲ GoodMajor
The rights issue shortfall was placed, raising $1.27m, plus a $392,610 follow-on placement on the same terms. Total tranche is $1.663m, on top of the $4.56m rights issue, bringing the total to $6.22m at $0.006 with attaching options.
31 July 2024capital raising announcement● NeutralMajor
The rights issue closed with valid applications for $4.56m, leaving 212.1m shares of shortfall that may be placed with strategic investors. Rare earths exploration timing depends on pursuing non-dilutive funding. That is short of the up to $5.8m targeted.
Reminder that the 2-for-3 rights issue at $0.006 closes 26 July, with Chairman Johnson ($1.172m) and MD Baghdadi ($0.8m) committed to take up in full. Shortfall may be placed within 3 months. Repeats known terms.
Prospectus for the renounceable 2-for-3 rights issue: about 972m new shares at $0.006 to raise about $5.83m, with attaching options. A minimum subscription of $1,974,691 applies, for which commitments are said to be received. It details the already announced terms.
What it means for a shareholder
972m new shares at $0.006 to raise about $5.8m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
8 July 2024capital raising announcement● NeutralMajor
Dateline replaces the withdrawn offer with a 2-for-3 renounceable rights issue at $0.006 to raise up to about $5.8m, with a free 1-for-2 attaching option at $0.02 over 24 months. Johnson (about $1.17m) and Baghdadi (about $0.8m) commit to take up in full. Funds are for exploration, mine planning and debt reduction.
The board withdraws the $0.01 rights issue announced 12 June and will return subscribed funds. Further funding details are promised for 8 July. This reverses the earlier raise, leaving the funding need unresolved for now.
Mahe Capital is appointed lead manager of the $4.2m rights issue and will place any shortfall, for a fee on amounts raised. It also gets 1 option per 2 shortfall shares issued, exercisable at $0.02 by 5 July 2024. The pro forma balance sheet is replaced.
12 June 2024capital raising announcement● NeutralMajor
Dateline launches a partially underwritten 1-for-3.5 non-renounceable rights issue at $0.01 to raise up to about $4.2m, for exploration, a mine planning study and debt reduction. Chairman Johnson (about $0.84m) and MD Baghdadi (about $0.57m) commit to take up their entitlements in full.
Offer booklet for the $0.01 per share, 1-for-3.5 rights issue of up to about $4.2m, closing 5 July 2024. It sets out the terms already announced and adds no new substance.
21 Feb 2024capital raising announcement● NeutralMajor
Dateline raised A$1.478m via a placement of 123.2m shares at $0.012, a 20% discount to five-day VWAP, with a 1-for-2 three-year option at $0.03 (options need shareholder approval). Funds go to Colosseum drilling and working capital, easing the low cash position.
What it means for a shareholder
123m new shares at $0.012 to raise about $1.5m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
31 Oct 2023capital raising announcement● NeutralMajor
The 1-for-1 rights issue at $0.01 closed with applications for 427.5m shares, raising $4.275m against the up-to-$8.85m target. Chairman Johnson and MD Baghdadi took up their entitlements and underwrote $1.5m of shortfall. About half the maximum was raised.
What it means for a shareholder
428m new shares at about $0.010 to raise about $4.3m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
Dateline confirms that a notice with participation instructions was dispatched to eligible shareholders on 16 October for the 1-for-1 rights issue at $0.01, raising up to about $8.85m. Administrative; no new terms or figures.
9 Oct 2023capital raising announcement● NeutralMajor
Dateline launches a 1-for-1 partially underwritten rights issue at $0.01 to raise up to about $8.85m, for Colosseum and Argos exploration, debt reduction and working capital. Directors Johnson and Baghdadi will take up entitlements and underwrite up to $1.5m of shortfall. The price is half the 2023 raise price of $0.02.
Offer booklet for the 1-for-1 rights issue at $0.01, raising up to about $8.85m, closing 5pm 27 October 2023. It is the formal document for the offer announced the same day and shows no new figures in the extract.
The rights issue closed with applications for only 5.14m shares, about $103,000, against roughly $1.1m targeted. The company will work with its broker to place up to $1m of shortfall, backed by Peak's commitment.
Offer booklet for the 1-for-12 rights issue at $0.02, raising up to about $1.1m, closing 5pm 31 March 2023. It is the formal document for the previously announced offer; the extract shows no new figures.
Dateline details its 1-for-12 non-renounceable rights issue at $0.02 to raise up to about $1.1m, for Colosseum exploration and working capital. Peak Asset Management has committed to take up to $1m of any shortfall. Offer closes 31 March 2023.
2 Mar 2023capital raising announcement● NeutralMajor
Dateline raises $2.71m through a placement of 135.5m shares at $0.02, with 67.75m options at $0.03 attached. Directors will convert up to $900k of debt to shares, and a ~$1m rights issue at $0.02 is planned. Funds go to Colosseum exploration and working capital.
19 Aug 2022capital raising announcement● NeutralMajor
Placement of 62.5m shares at $0.10 to raise $6.25m, a 17% discount, with 15.625m options at $0.135 over three years. Funds go to Colosseum gold and rare earths exploration and working capital. Part needs shareholder approval at a late September meeting.
What it means for a shareholder
62.5m new shares at $0.100 to raise about $6.3m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.
42,133,333 placement shares were allotted, completing most of the $4.1m raise at $0.09. The remaining 3,422,222 shares for directors Baghdadi and Ferguson need shareholder approval at a 24 September 2021 meeting.
23 July 2021capital raising announcement● NeutralMajor
Dateline raised about $4.1m via a placement of 45.6m shares at $0.09, a 14.3% discount to the last price. Directors Baghdadi and Ferguson will take $208k and $100k, subject to approval. Cash is stated at over $10.5m, funding Colosseum drilling and rare earths sampling.
What it means for a shareholder
45.6m new shares at $0.090 to raise about $4.1m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.